innovative platform technology

Innovative Technology Platform

Entera's innovative technology enables oral drug delivery of large molecules

27163516 pills

Pipeline of Drug Development

Entera conducts clinical trials of three oral drugs based on a proven active compound

27163516 brain green

Experienced Management Team

The managers of Entera have more than 50 years of experience in drug development

May 8, 2012 - Good interim results are obtained from the Phase 1 clinical trial with Entera's oral PTH 1-34 drug for osteoporosis. No side effects were observed in the 12 volunteers who orally received the drug. In addition, rapid absorption, short distribution time and rapid elimination of the drug indicate its potential as a drug.